Cite
HARVARD Citation
Ruggeri, M. et al. (2014). Cost-effectiveness analysis of transnasal fentanyl citrate for the treatment of breakthrough cancer pain. Expert review of pharmacoeconomics & outcomes research. pp. 459-464. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ruggeri, M. et al. (2014). Cost-effectiveness analysis of transnasal fentanyl citrate for the treatment of breakthrough cancer pain. Expert review of pharmacoeconomics & outcomes research. pp. 459-464. [Online].